|
|
Volumn 467, Issue 7316, 2010, Pages 633-
|
|
Editorial: Stem-cell laws in China fall short
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOETHICS;
CHINA;
CLINICAL EFFECTIVENESS;
CORD BLOOD STEM CELL TRANSPLANTATION;
DRUG INDUSTRY;
EDITORIAL;
EVIDENCE BASED MEDICINE;
GOVERNMENT;
HUMAN;
LAW;
MEDICAL TECHNOLOGY;
MULTIPLE SCLEROSIS;
MUSCULAR DYSTROPHY;
PATIENT SAFETY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PROFIT;
SPINAL CORD INJURY;
STEM CELL TRANSPLANTATION;
SYSTEMIC LUPUS ERYTHEMATOSUS;
CLINICAL STUDY;
CLINICAL TRIAL (TOPIC);
ETHICIST;
EVIDENCE BASED PRACTICE;
GOVERNMENT REGULATION;
LAW ENFORCEMENT;
MEDICAL ETHICS;
PHASE 1 CLINICAL TRIAL (TOPIC);
SCIENTIST;
CLINICAL TRIAL;
LEGAL ASPECT;
PATIENT ADVOCACY;
STANDARD;
STEM CELL;
CHINA;
CLINICAL TRIALS AS TOPIC;
EVIDENCE-BASED MEDICINE;
GOVERNMENT REGULATION;
GUIDELINES AS TOPIC;
HUMANS;
PATIENT ADVOCACY;
STEM CELL TRANSPLANTATION;
STEM CELLS;
|
|
EID: 84874553430
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/467633a Document Type: Editorial |
|
Times cited : (11)
|
|
References (0)
|